INNOVADERM CRO IS NOW INDERO.

Our Insights

FILTER BY:

Case Study

Urticaria Case Study

Case Study

Atopic Dermatitis (AD) Rescue Case Study

Case Study

A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product

Case Study

Plaque Psoriasis Case Study

Case Study

Nimbus Testimonial

Case Study

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)” – An Inmagene Biopharmaceuticals Testimonial

Case Study

Success Story: Support for Vitiligo Pre-IND Submission and FDA Meeting Preparation

Case Study

Testimonial: “Thanks to Indero’s adaptive approach, we sailed through our trial with ease!”

Case Study

Indero, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

Case Study

Generalized Pustular Psoriasis (GPP) Rescue Case Study

Case Study

Hidradenitis Suppurativa (HS) Case Study

Case Study

Palmoplantar Pustulosis (PPP) Case Study

Case Study

Notalgia Paresthetica (NP) Case Study

Case Study

Alopecia Areata (AA) Case Study

Case Study

Atopic Dermatitis (AD) Case Study

Case Study

Acne Case Study

FILTER BY:

News

Join Indero at the AID’s Dermatology Summit in San Francisco!

News

Indero Named Best Employer by Mercer

News

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

News

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

News

Indero is Returning to THE Annual USA Rheumatology Event!

News

Indero Showcasing Dermatology Expertise at EADV Congress in Paris

News

Meet Indero at SCDM 2025

News

Indero at EADV 2025—Supporting Innovation in Dermatology

News

Indero at ESDR 2025—Advancing Skin Science

FILTER BY:

Post

The Strategic Power of Public Relations in Scientific and Technical Industries

Post

Rethinking CRA Oversight

Post

What Sites Look for in Sponsors: A Practical Checklist

Post

Aligning With Patient Advocates in Trials

Post

A Site-Centric Approach to Protocol Usability

Post

Enhancing Representation: Strategies for Patient Centricity in Inclusive Clinical Trials

Post

Lessons From a Mercer-Recognized Best Employer

Post

Rheumatology Trial Checklist

Post

Effective Patient Recruitment Strategies for Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

FILTER BY:

White Paper

Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

White Paper

Leveraging Technology in Phase I Clinical Trials

FILTER BY:

Webinar

“Clinical Development Strategy that Patients Need and Investors Want” by Dr. Jasmina Jankicevic

Webinar

Dr. Robert Bissonnette and Dr. Kim Papp on Shaping the Future of Clinical Research

Webinar

On the Edge of Dermatology Early Phase Trials

Webinar

In-Person Breakfast Event at the AAD – Spotlight on Hidradenitis Suppurativa

Webinar

Clinical Trials Information System (CTIS)

Webinar

Tips For a Successful Study in Medical Aesthetics

Webinar

Non-invasive methods to study molecular biomarkers in the skin: Tape Stripping and Beyond

Webinar

Skin Barrier Dysfunction: Atopic Dermatitis and Beyond

Webinar

The Art of Protocol Writing in Dermatology

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.